Upcoming Programs and Events
The Herbert Irving Comprehensive Cancer Center hosts a variety of programs and events for our members, patients, and community.
If you would like your event posted on this webpage, please contact the Communications Office at cucancercomms@cumc.columbia.edu.
-
Categories
- Basic Health Sciences
- College of Physicians and Surgeons
- Graduate School of Arts and Sciences
- Teaching and Learning
- Research
Using iPSC lines to model human development across individuals
Flora Vaccarino, MD
Harris Professor in the Child Study Center; Director, Program in Neurodevelopment and Regeneration, Child Study Center;
Professor in the Department of Neuroscience
Hosted by Dr. Kristin Baldwin
-
Categories
- Clinical Health Sciences
- College of Physicians and Surgeons
- Mailman School of Public Health
- Research
The Columbia Summer Research Institute & the Biostatistics, Epidemiology, & Research Design resource of the Irving Institute are delighted to announce that we will be hosting a virtual lunchtime seminar on systematic reviews and meta-analyses.
Academic researchers and clinicians interested in developing their skills in research synthesis are welcome to join us on Wednesday, May 15th from 12 – 1pm where we will discuss:
• When to conduct a systematic review & meta-analysis
• How to identify appropriate topics for review
• How to assemble an effective study team
• Learn organizational strategies to guide the project in a reproducible manner
• Review steps of evidence synthesis to gain awareness of resource & time requirements
• Navigate challenges and pitfalls of evidence synthesis, such as handling hidden heterogeneity
Do not miss this free, virtual opportunity to learn how you can enhance your research toolkit!
Speakers: Jeffrey Birk, PhD & Talea Cornelius, PhD MSW
Register here
-
Categories
- College of Physicians and Surgeons
- Basic Health Sciences
Presenters:
AsiaLuna Patlis, Doege Lab
“SH2B1 signaling in iPSC-derived hypothalmic neurons”
Joan Castellano Perez, Taylor Lab
“Aneuploidy impact on basal cell differentiation and lung squamous cell carcinoma development”
-
Categories
- College of Physicians and Surgeons
On behalf of the Herbert Irving Comprehensive Cancer Center, we are pleased to announce the formation of the Columbia Brain Tumor Seminar Series. Seminars will take place on Thursdays at noon in the Florence Irving Auditorium on the first floor of the ICRC Building. The series will feature speakers from outside of Columbia, presenting their work on various aspects of neuro-oncology, ranging from the genes and pathways involved in tumor initiation and metastasis to the roles of the microenvironment and the immune system to novel approaches to therapy and drug delivery. In addition to their seminars, speakers will spend the day meeting with faculty and trainees, learning about the outstanding research happening at Columbia.
Talk Title: “Emerging role of target therapies in Glioma”
Speaker: Macarena de la Fuente, MD; Chief, Neuro-Oncology Division at University of Miami; Clinical Service Leader for Neuro-Oncology Service Line - Sylvester Comprehensive Cancer Center; Chair, Neuro-Oncology Site Disease Group
-
Categories
- Clinical Health Sciences
- Basic Health Sciences
- Mailman School of Public Health
- Research
Title: “Advancing Genomic Discoveries & Implementation: A focus on Underrepresented groups"
Seminar in Precision Medicine series, co-presented by the Center for Precision Medicine and Genomics, the Columbia Precision Medicine Initiative, and the Precision Medicine Resource of the Irving Institute for Clinical and Translational Research. This event is supported in part by a gift from Pfizer to Columbia.
Speaker: Nita A. Limdi, Pharm.D, Ph.D, MSPH, FAHA
Professor Department of Neurology & Epidemiology ; Director, Translational Pharmacogenomics Program; Associate Director, Hugh Kaul Precision Medicine Institute; Co-Director, CTSA Training Academy
With a focus on Drug therapy for Chronic Diseases, Limdi will present how observations at the bedside (as a clinical pharmacist) led her to the bench (research - epidemiologist) to study predictors (including genomics) of drug response.
Over 2 decades, her work has shed light on understanding variability in anticoagulant response in diverse populations - highlighting the influence of genes, comorbid conditions… and the importance of deep clinical phenotyping and robust study design and letting the data drive further exploration
A leader in pharmacogenomics consortia – she has collaborated extensively in evidence reviews and guideline development
Bringing this back to the bedside, she leads implementation of pharmacogenomics at UABHS and will be presenting some of this work
Finally, she will present UAB’s effort and collaborations in eMERGE, developing and returning polygenic risk scores for 10 conditions in a diverse in primary care population
Zoom and in-person. Please register to receive the Zoom link for the event.
Refreshments will be served!
-
Categories
- Basic Health Sciences
- Clinical Health Sciences
The Monthly Columbia Trainee Community Cancer Research Conference features trainees who are engaged in mentored cancer research as part of NIH-funded training grants. These trainees, ranging from predocs to junior faculty, will be given the opportunity to present their ongoing research and career development activities and a chance to network with their peers in the Cancer Center. This event will be hosted by CRTEC every third Thursday of each month from 4 to 5 pm.
We will use a hybrid format for this monthly conference, but all are encouraged to attend in person for pizza and refreshments. The zoom link is https://columbiacuimc.zoom.us/j/91948977720?pwd=L1Ftbk90UU1QTGtYd2FFekR0N1Z4UT09. The passcode is 266728. The in-person location is Conference Room 117, First Floor, Irving Cancer Research Center, 1130 St Nicholas Ave 2nd Floor, New York, NY 10032.
RSVP here.
-
Categories
- Basic Health Sciences
- Clinical Health Sciences
- College of Physicians and Surgeons
- Columbia Nursing
- Core Curriculum
- Education
- Healthcare
- Mailman School of Public Health
- School of Social Work
- Teaching and Learning
Program Overview
IN-PERSON & VIRTUAL CONFERENCE
The application of immunotherapies and cellular therapies in the treatment of cancer have provided tremendous insight into the functions of the immune system. Immunotherapies for solid cancers have greatly enhanced the care of many patients, but have also caused issues in the form of immune-related adverse events, with a multitude of acute and chronic autoimmune complications for patients. Similarly, cellular therapies such as CAR-T cell therapy have significantly improved the treatment of many hematologic malignancies, but have also revealed the potential for these treatments to cause cytokine storm and other severe complications. Research and development of these treatments have taught us a great deal about immune system regulation and dysregulation in general, providing insights into the pathogenesis of autoimmune disease and even stimulating exploration of treatments like CAR-T cell therapy in lupus and PD-1 agonist treatment in rheumatoid arthritis. In this CME course, we bring together the leading national and international experts from oncology, rheumatology, and multiple other specialties to provide a comprehensive overview of the latest insights into diagnosis, management, and future areas of exploration in the realms of cancer and autoimmune disease.
Video Access
Following the program, all registrants will have access to lecture video recordings for ONE month.
Learning Objectives
-Describe the pathobiology and clinical uses of cellular therapy and immunotherapy in cancer
-List the acute and chronic immune-related adverse events in cancer immunotherapy
-Describe the potential complications of cellular therapy in cancer
-Identify treatment strategies to mitigate adverse effects of cellular therapy and immunotherapy in cancer
-Understand the impact of immunotherapy and cellular therapy in patients with pre-existing autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Physicians (ACCME) Credit Designation Statement
Amedco LLC designates this live virtual activity for a maximum of 7.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
PAs may claim a maximum of 7.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of 7.25 hours.
-
Categories
- Clinical Health Sciences
- College of Dental Medicine
- College of Physicians and Surgeons
- Columbia Nursing
- Earth Institute
- Graduate School of Arts and Sciences
- Healthcare
- Mailman School of Public Health
- Research
REGISTER HERE
Join us for a day of insightful discussions, networking opportunities, and an interactive panel centered around diversity, equity and inclusion in clinical trials. Hear from physicians, patient advocates, nurse navigators, and more while learning how to help shape the future of healthcare.
Be a voice in the conversation around clinical trials and the importance of health equity and inclusion of diverse populations. Everyone, especially those from underrepresented communities, should have the opportunity to participate in clinical trials.
Our goal is to help inform and educate people about the importance of clinical trials while understanding how true diversity and inclusiveness will help improve the lives of people and communities throughout the world.
-
Venue
Hybrid Event Fairchild 700
The seminar has been canceled and will be rescheduled at a later date.
The Herbert and Florence Irving Institute for Cancer Dynamics will continue its seminar series on the topic of mathematical sciences underpinning cancer research during the 2022-2023 academic year. The monthly seminars take place on the second Wednesday of the month, 2:00-3:00 PM EST. The presentations are open to the Columbia community (in person and online) and to researchers outside Columbia (via Zoom). On Wednesday, May 21st (2:00 PM ET), IICD welcomes Livnat Jerby, Assistant Professor, Department of Genetics, Stanford University. Seminar hosted by Sanja Vickovic. The seminar will take place in person in Fairchild 700 (Morningside Heights campus).
Title: Decoding and Rewiring Anti-Tumor Immune Responses
Abstract: Complex phenotypes often result from the collective behavior of diverse cell populations, as manifested in the remarkable ability of the immune system to distinguish between “self” and “non/dysfunctional-self”. In this talk I will describe our ongoing efforts to probe, trigger, and rewire immune responses in new and more precise ways. The first part of the talk will focus on studies aiming to uncover gene function and perturbation effects through the lens of multicellular regulation by mapping the spatial organization of tumors across large patient populations in combination with data-driven experimental design and high content CRISPR screens. This line of studies is beginning to map the genetic basis of cancer immune evasion and reveal new (RNA-based) mechanisms to selectively sensitize (only) cancer cells to immune attacks. In the second part of the talk, I will describe how we are using (epi)genetic editing in combination with directed evolution to engineer immune cells to sense cancer cells in new ways and better migrate and infiltrate into tumors. This line of studies revealed a yet underappreciated metabolite-based cancer-immune interplay that provides a new path to recruit engineered lymphocytes to the tumor via (epi)genetic activation of metabolite sensing receptors.
Bio: Livnat Jerby is an Assistant Professor in the Department of Genetics at Stanford University, a Chan Zuckerberg Biohub Investigator, and a Paul Allen Distinguished Investigator. Livnat leads a multidisciplinary research team that is pursuing novel avenues to tackle fundamental challenges in studying and leveraging multicellular processes as a disease driver and therapeutic modality. Using engineering-based, high-throughput approaches, her laboratory develops "hybrid" platforms across in-vitro/in-vivo/in-silico systems to identify new immunomodulating mechanisms and interventions. Recent work from her lab uncovered previously underappreciated aspects of the anti-tumor immune response and new modalities for immune cell engineering. Before joining Stanford, Livnat was a postdoctoral fellow in Aviv Regev’s lab at the Broad Institute of MIT and Harvard. She was among the first to use single cell genomics to study resistance to immunotherapy directly in patients and subsequently in combination with single cell CRISPR screens. Livnat holds a BSc in Computer Science and Biology and obtained her PhD from Tel Aviv University, where she worked with Eytan Ruppin, studying genetic interactions in cancer.
If you would like to meet one-on-one (possibility via zoom) or attend the lunch or dinner with the speaker, please contact the event organizer.
-
Categories
- Clinical Health Sciences
- College of Physicians and Surgeons
- College of Dental Medicine
- Healthcare
- Mailman School of Public Health
- Research
The Community Health Equity Series will focus on developing a common operational definition of Health Equity, Community Engagement, and Community Based Participatory Research principles from an action-oriented and civic engagement perspective.
Seminar Dates:
Virtual sessions, 3:30PM-5PM:
April 2
April 16
April 30
May 7
May 14
May 21
You may register for one, multiple, or all sessions. Participants that attend 5 out of the 6 sessions will receive a non-credit bearing certificate of participation.
Registrration Deadline: Friday at 5 pm before each session.
Seminar Topics:
April 2: Civic Engagement and Advocacy
April 16: Historicizing Inequities
April 30: Commuity Based Participatory Principles
May 7: CBPR in Action: Research Policy and Power Framework
May 14: Responding to Community Priorities
May 21: Integrating Civic Engagement into Wellness Programs
Pages